171 related articles for article (PubMed ID: 33930475)
41. [Phenotypic variations of susceptibility in Klebsiella pneumoniae strains of nosocomial origin and their association with biofilm formation].
Barreto S; Zambrano M; Araque M
Invest Clin; 2009 Jun; 50(2):221-9. PubMed ID: 19662817
[TBL] [Abstract][Full Text] [Related]
42. [Investigation of a nosocomial outbreak caused by ESBL positive Klebsiella pneumoniae in neonatal intensive care unit by AP-PCR].
Hoşbul T; Ozyurt M; Karademir F; Süleymanoğlu S; Haznedaroğlu T
Mikrobiyol Bul; 2012 Jan; 46(1):101-5. PubMed ID: 22399177
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of the Clinical and Laboratory Standards Institute phenotypic confirmatory test to detect the presence of extended-spectrum β-lactamases from 4005 Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates.
Morrissey I; Bouchillon SK; Hackel M; Biedenbach DJ; Hawser S; Hoban D; Badal RE
J Med Microbiol; 2014 Apr; 63(Pt 4):556-561. PubMed ID: 24478449
[TBL] [Abstract][Full Text] [Related]
44. Identification of
Validi M; Soltan Dallal MM; Douraghi M; Fallah Mehrabadi J; Rahimi Foroushani A
Osong Public Health Res Perspect; 2016 Oct; 7(5):301-306. PubMed ID: 27812488
[TBL] [Abstract][Full Text] [Related]
45. Phenotypic properties of Klebsiella pneumoniae and K. oxytoca isolated from different sources.
Podschun R
Zentralbl Hyg Umweltmed; 1990 May; 189(6):527-35. PubMed ID: 2200423
[TBL] [Abstract][Full Text] [Related]
46. Characterization of a multidrug-resistant Klebsiella pneumoniae ST3330 clone responsible for a nosocomial outbreak in a neonatal intensive care unit.
Shao L; Yao B; Yang J; Li X; Ye K; Zhang Y; Wang C
Ann Palliat Med; 2020 May; 9(3):1092-1102. PubMed ID: 32434364
[TBL] [Abstract][Full Text] [Related]
47. Successful control of a neonatal outbreak caused mainly by ST20 multidrug-resistant SHV-5-producing Klebsiella pneumoniae, Greece.
Mavroidi A; Liakopoulos A; Gounaris A; Goudesidou M; Gaitana K; Miriagou V; Petinaki E
BMC Pediatr; 2014 Apr; 14():105. PubMed ID: 24742105
[TBL] [Abstract][Full Text] [Related]
48. Inhibitory effect of trisodium citrate on biofilms formed by Klebsiella pneumoniae.
Chu L; Zhou X; Shen Y; Yu Y
J Glob Antimicrob Resist; 2020 Sep; 22():452-456. PubMed ID: 32387258
[TBL] [Abstract][Full Text] [Related]
49. Isolation of genes involved in biofilm formation of a Klebsiella pneumoniae strain causing pyogenic liver abscess.
Wu MC; Lin TL; Hsieh PF; Yang HC; Wang JT
PLoS One; 2011; 6(8):e23500. PubMed ID: 21858144
[TBL] [Abstract][Full Text] [Related]
50. Genetic Characterization of CTX-M-2-Producing
Tsuka T; Ozaki H; Saito D; Murase T; Okamoto Y; Azuma K; Osaki T; Ito N; Murahata Y; Imagawa T
Front Vet Sci; 2021; 8():659222. PubMed ID: 34026894
[TBL] [Abstract][Full Text] [Related]
51. Understanding the Interactions between
Chen X; Hu Y; Tian S; Han B
Microorganisms; 2021 Mar; 9(4):. PubMed ID: 33805148
[TBL] [Abstract][Full Text] [Related]
52. A new assay for the simultaneous identification and differentiation of Klebsiella oxytoca strains.
Stojowska-Swędrzyńska K; Krawczyk B
Appl Microbiol Biotechnol; 2016 Dec; 100(23):10115-10123. PubMed ID: 27717967
[TBL] [Abstract][Full Text] [Related]
53. E. coli, K. pneumoniae and K. oxytoca community-acquired infections susceptibility to cephalosporins and other antimicrobials in Lebanon.
Moghnieh RA; Musharrafieh UM; Husni RN; Abboud E; Haidar M; Abboud E; Abou Shakra D
J Med Liban; 2014; 62(2):107-12. PubMed ID: 25011373
[TBL] [Abstract][Full Text] [Related]
54. Cytotoxic and pathogenic properties of Klebsiella oxytoca isolated from laboratory animals.
Darby A; Lertpiriyapong K; Sarkar U; Seneviratne U; Park DS; Gamazon ER; Batchelder C; Cheung C; Buckley EM; Taylor NS; Shen Z; Tannenbaum SR; Wishnok JS; Fox JG
PLoS One; 2014; 9(7):e100542. PubMed ID: 25057966
[TBL] [Abstract][Full Text] [Related]
55. Study on the inhibition activity and mechanism of Tanreqing against
Zhang W; He M; Kong N; Niu Y; Li A; Yan Y
Front Cell Infect Microbiol; 2024; 14():1368450. PubMed ID: 38638833
[TBL] [Abstract][Full Text] [Related]
56. [ESBL-positive and ESBL-negative Klebsiella pneumoniae and Klebsiella oxytoca strains--occurrence in clinical specimens and susceptibility to selected antibiotics].
Sekowska A; Wróblewska J; Gospodarek E
Med Dosw Mikrobiol; 2008; 60(1):39-44. PubMed ID: 18634342
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China.
Li Y; Li Q; Du Y; Jiang X; Tang J; Wang J; Li G; Jiang Y
J Clin Microbiol; 2008 Apr; 46(4):1317-21. PubMed ID: 18305137
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of ompK36 allele groups on clinical characteristics and virulence features of Klebsiella pneumoniae from bacteremia.
Du F; Wei DD; Wan LG; Cao XW; Zhang W; Liu Y
J Microbiol Immunol Infect; 2019 Oct; 52(5):779-787. PubMed ID: 30348614
[TBL] [Abstract][Full Text] [Related]
59. A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates.
Tofteland S; Dahl KH; Aasnæs B; Sundsfjord A; Naseer U
Scand J Infect Dis; 2012 Dec; 44(12):927-33. PubMed ID: 22991975
[TBL] [Abstract][Full Text] [Related]
60. [Biological characteristics and genomic information of a bacteriophage against pan-drug resistant
Qi ZY; Yang SY; Dong SW; Zhao FF; Qin JH; Xiang J
Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):14-23. PubMed ID: 32023713
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
